From June 27 to 30, the Enhalor International team gathered in Harbin, China, for the 2026 Mid-Year Review Meeting. The meeting provided an important opportunity to review our progress in the first half of the year, align our international strategy, and prepare for the next stage of global growth.

During the meeting, the team reviewed the performance of Enhalor’s international business, shared insights from regional markets, and strengthened collaboration across cross-regional teams. Product training sessions further highlighted the competitive advantages of Enhalor’s solutions and reinforced our commitment to delivering greater value to customers around the world.

Dr. Ren Zelin, Chairman of Enhalor, emphasized that sustainable global growth is built on professional expertise, technological innovation, and continuous learning. Looking ahead, Enhalor will continue to invest in synthetic biology, strengthen its proprietary biotechnology platform, and deepen partnerships with customers and partners worldwide.

We are pleased to share that, in the first half of 2026, Enhalor achieved:

• 23.43% year-on-year growth in overseas product sales volume

• 24.20% year-on-year growth in overseas sales revenue

These results demonstrate not only steady business growth, but also the trust that global customers place in Enhalor’s technology, product quality, and professional service.

In addition to the formal meeting agenda, the international team also took part in team-building activities, further enhancing collaboration, shared purpose, and the collective commitment to delivering long-term value to customers worldwide.

We sincerely thank our customers, partners, and colleagues for their continued trust and support. Enhalor looks forward to growing together and creating greater value for the global animal nutrition industry.

#Enhalor #AnimalNutrition #Biotechnology #GlobalBusiness #Innovation #CustomerValue #Teamwork #SustainableGrowth